Ovid Therapeutics (OVID) seasonality heatmap
Returns across monthly, quarterly, and yearly periods. Cell color encodes signed magnitude; the scale auto-fits each table.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.3% | +4.5% | +36.2% | +24.8% | -1.4% | -15.8% | — | — | — | — | — | — |
| 2025 | -28.9% | -20.1% | -41.2% | +4.9% | -16.8% | +21.2% | +51.6% | +156.0% | +1.6% | +6.9% | +28.1% | -8.4% |
| 2024 | +20.2% | -12.1% | -10.3% | +0.0% | +0.3% | -74.9% | +35.2% | +8.7% | +4.4% | -4.2% | +0.9% | -18.1% |
| 2023 | +34.4% | -1.2% | +4.5% | +38.8% | -1.1% | -7.3% | +9.5% | -6.1% | +13.9% | -7.6% | -16.1% | +8.1% |
| 2022 | -14.0% | +22.8% | -7.4% | -12.4% | -38.5% | +27.2% | -4.7% | -2.0% | -8.5% | -11.4% | +8.6% | +5.1% |
| 2021 | +21.6% | +5.0% | +36.3% | -8.7% | +13.1% | -5.8% | -4.6% | -5.4% | -4.8% | +1.2% | -1.5% | -4.2% |
| 2020 | -13.3% | -8.9% | -9.1% | +22.1% | +47.0% | +37.8% | -12.5% | -11.0% | +0.0% | -11.0% | +33.9% | -66.2% |
| 2019 | +16.9% | -27.2% | -14.1% | +15.3% | -21.6% | +15.6% | +10.3% | -13.2% | +83.1% | -28.7% | +84.4% | -2.6% |
| 2018 | -13.9% | -22.5% | +7.3% | +34.1% | -16.8% | -1.1% | +27.9% | -33.2% | -15.0% | -9.5% | -21.4% | -40.0% |
| 2017 | — | — | — | — | — | -17.7% | -21.9% | +15.0% | -9.0% | -24.4% | +90.0% | -19.8% |
| Avg | +2.1% | -6.6% | +0.2% | +13.2% | -4.0% | -0.6% | +10.1% | +12.1% | +7.3% | -9.9% | +23.0% | -16.2% |
| Median | -4.3% | -8.9% | -7.4% | +15.3% | -1.4% | -1.1% | +9.5% | -5.4% | +0.0% | -9.5% | +8.6% | -8.4% |
| Last 5Y Avg | +1.5% | -1.2% | -3.6% | +11.2% | -11.5% | -7.9% | +17.4% | +30.2% | +1.3% | -3.0% | +4.0% | -3.5% |
| Std Dev (σ) | 21.6% | 16.0% | 24.6% | 18.3% | 24.4% | 33.3% | 24.1% | 55.7% | 29.7% | 11.2% | 40.6% | 23.8% |
| Consistency (μ/σ) | 0.10 | -0.41 | 0.01 | 0.72 | -0.16 | -0.02 | 0.42 | 0.22 | 0.25 | -0.88 | 0.57 | -0.68 |
| Win Rate (%) | 44% | 33% | 44% | 67% | 33% | 44% | 56% | 33% | 44% | 22% | 67% | 22% |
| Winning / Losing Months | ▲4▼5 | ▲3▼6 | ▲4▼5 | ▲6▼3 | ▲3▼6 | ▲4▼5 | ▲5▼4 | ▲3▼6 | ▲4▼5 | ▲2▼7 | ▲6▼3 | ▲2▼7 |
| Longest Win / Loss Streak | ▲2▼2 | ▲2▼3 | ▲1▼2 | ▲3▼2 | ▲2▼2 | ▲2▼2 | ▲3▼3 | ▲2▼6 | ▲3▼3 | ▲1▼4 | ▲2▼1 | ▲2▼5 |
| Best | +34.4%in January 2023 | +22.8%in February 2022 | +36.3%in March 2021 | +38.8%in April 2023 | +47.0%in May 2020 | +37.8%in June 2020 | +51.6%in July 2025 | +156.0%in August 2025 | +83.1%in September 2019 | +6.9%in October 2025 | +90.0%in November 2017 | +8.1%in December 2023 |
| Worst | -28.9%in January 2025 | -27.2%in February 2019 | -41.2%in March 2025 | -12.4%in April 2022 | -38.5%in May 2022 | -74.9%in June 2024 | -21.9%in July 2017 | -33.2%in August 2018 | -15.0%in September 2018 | -28.7%in October 2019 | -21.4%in November 2018 | -66.2%in December 2020 |
−74.9%+156.0%
2026
Jan-4.3%
Feb+4.5%
Mar+36.2%
Apr+24.8%
May-1.4%
Jun-15.8%
Jul—
Aug—
Sep—
Oct—
Nov—
Dec—
2025
Jan-28.9%
Feb-20.1%
Mar-41.2%
Apr+4.9%
May-16.8%
Jun+21.2%
Jul+51.6%
Aug+156.0%
Sep+1.6%
Oct+6.9%
Nov+28.1%
Dec-8.4%
2024
Jan+20.2%
Feb-12.1%
Mar-10.3%
Apr+0.0%
May+0.3%
Jun-74.9%
Jul+35.2%
Aug+8.7%
Sep+4.4%
Oct-4.2%
Nov+0.9%
Dec-18.1%
2023
Jan+34.4%
Feb-1.2%
Mar+4.5%
Apr+38.8%
May-1.1%
Jun-7.3%
Jul+9.5%
Aug-6.1%
Sep+13.9%
Oct-7.6%
Nov-16.1%
Dec+8.1%
2022
Jan-14.0%
Feb+22.8%
Mar-7.4%
Apr-12.4%
May-38.5%
Jun+27.2%
Jul-4.7%
Aug-2.0%
Sep-8.5%
Oct-11.4%
Nov+8.6%
Dec+5.1%
2021
Jan+21.6%
Feb+5.0%
Mar+36.3%
Apr-8.7%
May+13.1%
Jun-5.8%
Jul-4.6%
Aug-5.4%
Sep-4.8%
Oct+1.2%
Nov-1.5%
Dec-4.2%
2020
Jan-13.3%
Feb-8.9%
Mar-9.1%
Apr+22.1%
May+47.0%
Jun+37.8%
Jul-12.5%
Aug-11.0%
Sep+0.0%
Oct-11.0%
Nov+33.9%
Dec-66.2%
2019
Jan+16.9%
Feb-27.2%
Mar-14.1%
Apr+15.3%
May-21.6%
Jun+15.6%
Jul+10.3%
Aug-13.2%
Sep+83.1%
Oct-28.7%
Nov+84.4%
Dec-2.6%
2018
Jan-13.9%
Feb-22.5%
Mar+7.3%
Apr+34.1%
May-16.8%
Jun-1.1%
Jul+27.9%
Aug-33.2%
Sep-15.0%
Oct-9.5%
Nov-21.4%
Dec-40.0%
2017
Jan—
Feb—
Mar—
Apr—
May—
Jun-17.7%
Jul-21.9%
Aug+15.0%
Sep-9.0%
Oct-24.4%
Nov+90.0%
Dec-19.8%
Avg
Jan+2.1%
Feb-6.6%
Mar+0.2%
Apr+13.2%
May-4.0%
Jun-0.6%
Jul+10.1%
Aug+12.1%
Sep+7.3%
Oct-9.9%
Nov+23.0%
Dec-16.2%
Median
Jan-4.3%
Feb-8.9%
Mar-7.4%
Apr+15.3%
May-1.4%
Jun-1.1%
Jul+9.5%
Aug-5.4%
Sep+0.0%
Oct-9.5%
Nov+8.6%
Dec-8.4%
Last 5Y Avg
Jan+1.5%
Feb-1.2%
Mar-3.6%
Apr+11.2%
May-11.5%
Jun-7.9%
Jul+17.4%
Aug+30.2%
Sep+1.3%
Oct-3.0%
Nov+4.0%
Dec-3.5%
Std Dev (σ)
Jan21.6%
Feb16.0%
Mar24.6%
Apr18.3%
May24.4%
Jun33.3%
Jul24.1%
Aug55.7%
Sep29.7%
Oct11.2%
Nov40.6%
Dec23.8%
Consistency (μ/σ)
Jan0.10
Feb-0.41
Mar0.01
Apr0.72
May-0.16
Jun-0.02
Jul0.42
Aug0.22
Sep0.25
Oct-0.88
Nov0.57
Dec-0.68
Win Rate (%)
Jan44%
Feb33%
Mar44%
Apr67%
May33%
Jun44%
Jul56%
Aug33%
Sep44%
Oct22%
Nov67%
Dec22%
Winning / Losing Months
Jan▲4▼5
Feb▲3▼6
Mar▲4▼5
Apr▲6▼3
May▲3▼6
Jun▲4▼5
Jul▲5▼4
Aug▲3▼6
Sep▲4▼5
Oct▲2▼7
Nov▲6▼3
Dec▲2▼7
Longest Win / Loss Streak
Jan▲2▼2
Feb▲2▼3
Mar▲1▼2
Apr▲3▼2
May▲2▼2
Jun▲2▼2
Jul▲3▼3
Aug▲2▼6
Sep▲3▼3
Oct▲1▼4
Nov▲2▼1
Dec▲2▼5
Best
Jan+34.4%2023
Feb+22.8%2022
Mar+36.3%2021
Apr+38.8%2023
May+47.0%2020
Jun+37.8%2020
Jul+51.6%2025
Aug+156.0%2025
Sep+83.1%2019
Oct+6.9%2025
Nov+90.0%2017
Dec+8.1%2023
Worst
Jan-28.9%2025
Feb-27.2%2019
Mar-41.2%2025
Apr-12.4%2022
May-38.5%2022
Jun-74.9%2024
Jul-21.9%2017
Aug-33.2%2018
Sep-15.0%2018
Oct-28.7%2019
Nov-21.4%2018
Dec-66.2%2020
−74.9%+156.0%
Frequently asked questions
Data & methodology
Ovid Therapeutics (OVID) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement